43. Luo J, Sands M, Wactawski-Wende J, Song Y, Margolis KL. Sleep
disturbance and incidence of thyroid cancer in postmenopausal women: The
Women’s Health Initiative. Am J Epidemiol 2013;177: 42–9.
44. Nieto FJ, Peppard PE, Young T, Finn L, Hla KM, Farré R. Sleep-disordered
breathing and cancer mortality. Am J Respir Crit Care Med 2012;186:190– 4.
45. Boyko EJ, Seelig AD, Jacobson IG, Hooper TI, Smith B, Smith TC, et al. Sleep
characteristics, mental health, and diabetes risk: A prospective study of U.S.
military service members in the Millennium Cohort Study. Diabetes Care
2013 Jul 8. [Epub ahead of print].
46. Nock NL, Berger NA. Obesity and cancer, overview and mechanisms. In:
Berger NA, editor. Cancer and energy balance, epidemiology and overview.
Energy balance and cancer, volume 2. New York: Springer; 2010. p.
47. Kondratov RV, Antoch MP. Circadian proteins in the regulation of cell cycle
and genotoxic stress responses. Trends Cell Biol 2007;17:311–7.
48. Blask DE. Melatonin, sleep disturbance and cancer risk. Sleep Med Rev
49. Kang TH, Sancar A. Circadian regulation of DNA excision repair: Implications
for chrono-chemotherapy. Cell Cycle 2009;8:1665–7.
50. Kang TH, Reardon JT, Kemp M, Sancar A. Circadian oscillation of
nucleotide excision repair in mammalian brain. Proc Natl Acad Sci U S A
51. Berger NA, editor. Energy balance and cancer. New York: Springer; 2010.
52. Hursting SD, DiGiovanni J, Dannenberg AJ, Azrad M, LeRoith D, Demark-Wahnefried W, et al. Obesity, energy balance, and cancer: new opportunities
for prevention. Cancer Prev Res (Phila) 2012;5:1260–72.
53. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity,
and mortality from cancer in a prospectively studied cohort of U.S. adults. N
Engl J Med 2003;348:1625–38.
54. Eheman C, Henley SJ, Ballard-Barbash R, Jacobs EJ, Schymura MJ, Noone
A-M, et al. Annual Report to the Nation on the status of cancer, 1975-2008,
featuring cancers associated with excess weight and lack of sufficient
physical activity. Cancer. 2012;118:2338-66.
55. Dannenberg AJ, Berger NA. Obesity, inflammation and cancer: new
opportunities for prevention. Cancer Prev Res (Phila) 2012;5:1260–72.
56. Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of obesity in the United
States, 2009-2010. NCHS Data Brief. 2012 Jan;( 82): 1-8.
57. Gianni L, Dafni U, Gelber RD, Azambuja E, Muehlbauer S, Goldhirsch A, et
al. Treatment with trastuzumab for 1 year after adjuvant chemotherapy in
patients with HER2-positive early breast cancer: a 4-year follow-up of a
randomised controlled trial. Lancet Oncol 2011;12:236–44.
58. Habib SL, Rojna M. Diabetes and Risk of Cancer. ISRN Oncol 2013;2013: 16.
59. Giovannucci E, Harlan DM, Archer MC, Bergenstal RM, Gapstur SM, Habel
LA, et al. Diabetes and Cancer: A Consensus Report. CA Cancer J Clin
60. Jeon JY, Jeong DH, Park MG, Lee J-W, Chu SH, Park J-H, et al. Impact of
Diabetes on Oncologic Outcome of Colorectal Cancer Patients: Colon vs.
Rectal Cancer. PLoS ONE. 2013;8:e55196.
61. Centers for Disease Control and Prevention. 2011 National Diabetes Fact
Sheet. [cited 2013 July 31]; Available from: http://www.cdc.gov/diabetes/
62. Currie CJ, Poole CD, Gale EAM. The influence of glucose-lowering therapies
on cancer risk in type 2 diabetes. Diabetologia 2009;52:1766–77.
63. Li D. Diabetes and pancreatic cancer. Mol Carcinog 2012;51: 64–74.
64. Quinn BJ, Kitagawa H, Memmott RM, Gills JJ, Dennis PA. Repositioning
metformin for cancer prevention and treatment. Trends Endocrinol Metab
2013 Jun 14. [Epub ahead of print].
65. Schmitz KH, Courneya KS, Matthews C, Demark-Wahnefried W, GALVÃO
DA, Pinto BM, et al. American College of Sports Medicine Roundtable
on Exercise Guidelines for Cancer Survivors. Med Sci Sports Exerc.
66. Rock CL, Doyle C, Demark-Wahnefried W, Meyerhardt J, Courneya KS,
Schwartz AL, et al. Nutrition and physical activity guidelines for cancer
survivors. CA Cancer J Clin 2012;62:242–74.
67. Boyle T, Fritschi L, Heyworth J, Bull F. Long-term sedentary work and the
risk of subsite-specific colorectal cancer. Am J Epidemiol 2011;173:1183–
68. Campbell PT, Patel AV, Newton CC, Jacobs EJ, Gapstur SM. Associations of
recreational physical activity and leisure time spent sitting with colorectal
cancer survival. J Clin Oncol 2013;31:876–85.
69. Patel AV, Bernstein L, Deka A, Feigelson HS, Campbell PT, Gapstur SM, et al.
Leisure time spent sitting in relation to total mortality in a prospective cohort
of US adults. Am J Epidemiol 2010;172:419–29.
70. Meyerhardt JA, Giovannucci EL, Holmes MD, Chan AT, Chan JA, Colditz GA,
et al. Physical activity and survival after colorectal cancer diagnosis. J Clin
71. Ballard-Barbash R, Friedenreich CM, Courneya KS, Siddiqi SM, Mc Tiernan
A, Alfano CM. Physical activity, biomarkers, and disease outcomes in cancer
survivors: a systematic review. J Natl Cancer Inst 2012;104:815–40.
72. Cao Y, Ma J. Body mass index, prostate cancer–specific mortality, and
niochemical recurrence: a systematic review and meta-analysis. Cancer
Prev Res (Phila) 2011;4:486–501.
73. Irwin ML. Benefits of aerobic and resistance exercise for cancer survivors.
In: Ulrich CM, et al., editors. Exercise, energy balance, and cancer. Energy
balance and cancer, vol. 6. New York: Springer; 2013 p. 199–213.
74. Mattar MC, Lough D, Pishvaian MJ, Charabaty A. Current management of
inflammatory bowel disease and colorectal cancer. Gastrointest Cancer Res
75. Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM. Incidence of cancers
in people with HIV/AIDS compared with immunosuppressed transplant
recipients: a meta-analysis. Lancet 2007;370: 59–67.
76. Laara E, Day NE, Hakama M. Trends in mortality from cervical cancer in the
Nordic countries: association with organised screening programmes. Lancet
77. Cervical Cancer. [cited 2012 August 31]; Available from: http://www.cancer.
78. Centers for Disease Control and Prevention. Cancer screening —United
States, 2010. MM WR Morb Mortal Wkly Rep 2012;61: 41–5.
79. Vital signs: Colorectal cancer screening, incidence, and mortality—United
States, 2002–2010. MMWR Morb Mortal Wkly Rep 2011;60:884–9.
80. Siegel R, Jemal A. Colorectal cancer facts & Figures, 2011–2013. Atlanta,
GA: American Cancer Society; 2011.
81. Grubbs SS, Polite BN, Carney J Jr, Bowser W, Rogers J, Katurakes N, et al.
Eliminating racial disparities in colorectal cancer in the real world: it took a
village. J Clin Oncol 2013;31:1928–30.
82. U.S. Census Bureau. 2008 National Population Projections: Table 4
Projections of the Population by Sex, Race, and Hispanic Origin for the
United States: 2010 to 2050. 2008 National Population Projections:
Summary Tables. 2008 [cited 2013 July 31]; Available from: http://www.
83. Gross CP, Smith BD, Wolf E, Andersen M. Racial disparities in cancer
therapy: Did the gap narrow between 1992 and 2002? Cancer
84. American Cancer Society. Cancer facts and figures for African Americans
2013-2014. Atlanta, GA: American Cancer Society; 2013.
85. Fejerman L, Romieu I, John EM, Lazcano-Ponce E, Huntsman S, Beckman
KB, et al. European ancestry is positively associated with breast cancer risk
in Mexican Women. Cancer Epidemiol Biomarkers Prev 2010;19:1074–82.
86. Maskarinec G, Noh JJ. The effect of migration on cancer incidence among
Japanese in Hawaii. Ethn Dis 2004;14:431–9.
87. Kaiser Family Foundation. Health coverage by race and ethnicity: the
potentialimpact of the Affordable Care Act. Washington, DC: Kaiser Family